The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
Open accessAbstract
Liver membranes from young beagle dogs were found to possess binding sites that resemble the low density lipoprotein (LDL) receptors originally described in cultured human fibroblasts. Treatment of the dogs with colestipol (a bile acid sequestrant) and mevinolin (a cholesterol synthesis inhibitor) produced a 3-fold increase in LDL binding activity. This increase correlated with a 2-fold increase in the fractional catabolic rate for intravenously administered human or canine 125I-labeled LDL, suggesting that the increased hepatic receptors were responsible for the enhanced clearance of LDL from plasma. The hepatic lipoprotein receptors of control and drug-treated dogs resembled human fibroblast LDL receptors in that they bound apoprotein E-containing lipoproteins, such as very low density lipoproteins and a subfraction of high density lipoproteins (HDL1), with 10-fold higher affinity than the apoprotein B-containing lipoprotein LDL; failed to bind canine HDL2 and human HDL3, which are devoid of apoproteins B and E; failed to bind methylated LDL; required calcium; and were destroyed by Pronase. Treatment of dogs with mevinolin not only increased the fractional catabolic rate for LDL but also reduced the synthetic rate for the lipoprotein. The current data suggest that the liver of dogs contains functional LDL receptors that are susceptible to metabolic regulation and that a drug-induced increase in the activity of these receptors can contribute to a lowering of plasma levels of LDL-cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
Self-citationAlberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
A graphic method for the determination and presentation of binding parameters in a complex system
Rosenthal, H. E. (1967) · Analytical Biochemistry · doi:10.1016/0003-2697(67)90297-7 · Cited by 1,512
The Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine & Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 829
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 794
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34284-9 · Cited by 618
Kovanen, P. T., Brown, M. S., & Goldstein, J. L. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86495-5 · Cited by 564
Self-citationBrown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I., & Endo, A. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38120-6 · Cited by 556
Self-citation
Cited by
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationA Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Goldstein, J. L., & Brown, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.01.036 · Cited by 1,233
Self-citationLovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 875
Dietschy, J., Turley, S., & Spady, D. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35728-x · Cited by 874
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 758
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Self-citationSirtori, C. R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.002 · Cited by 691
Bilheimer, D. W., Grundy, S. M., Brown, M. S., & Goldstein, J. L. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.4124 · Cited by 557
Self-citationLipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
Brown, M. S., & Goldstein, J. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111044 · Cited by 545
Self-citationEpstein, F. H., Goldstein, J. L., Kita, T., & Brown, M. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090507 · Cited by 469
Self-citationBilheimer, D. W., Goldstein, J. L., Grundy, S. M., Starzl, T. E., & Brown, M. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412273112603 · Cited by 442
Self-citationLipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383
Goldstein, J. L., & Brown, M. S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34418-7 · Cited by 383
Self-citationMahley, R. W., Hui, D. Y., Innerarity, T. L., & Weisgraber, K. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110365 · Cited by 375
Discovery, biochemistry and biology of lovastatin
Alberts, A. W. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90002-1 · Cited by 358
PCSK9 is a critical regulator of the innate immune response and septic shock outcome
Walley, K. R., Thain, K. R., Russell, J. A., Reilly, M. P., Meyer, N. J., Ferguson, J. F., Christie, J. D., Nakada, T.-A., Fjell, C. D., Thair, S. A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008782 · Cited by 355
Ma, P. T., Gil, G., Südhof, T. C., Bilheimer, D. W., Goldstein, J. L., & Brown, M. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8370 · Cited by 334
Self-citationSpady, D. K., & Dietschy, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4526 · Cited by 315
Kovanen, P. T., Brown, M. S., Basu, S. K., Bilheimer, D. W., & Goldstein, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1396 · Cited by 311
Self-citationSchneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110330 · Cited by 310
Self-citationLipoproteins and atherosclerosis. A look back and a look ahead.
Steinberg, D. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.4.283 · Cited by 307
Role of cholesterol in the function and organization of G-protein coupled receptors
Pucadyil, T. J., & Chattopadhyay, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.02.002 · Cited by 296
Vasile, E., Simionescu, M., & Simionescu, N. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.6.1677 · Cited by 294
Babu, P. S., & Srinivasan, K. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006819605211 · Cited by 282
Reihnér, E., Rudling, M., Ståhlberg, D., Berglund, L., Ewerth, S., Björkhem, I., Einarsson, K., & Angelin, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230403 · Cited by 277
Mahley, R. W. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31426-2 · Cited by 272
Absorption and Metabolism of Dietary Cholesterol
Grundy, S. M. (1983) · Annual Review of Nutrition · doi:10.1146/annurev.nu.03.070183.000443 · Cited by 271
Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262
Kita, T., Brown, M. S., Watanabe, Y., & Goldstein, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2268 · Cited by 255
Self-citationOsono, Y., Woollett, L. A., Herz, J., & Dietschy, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117760 · Cited by 169
Kita, T., Goldstein, J. L., Brown, M. S., Watanabe, Y., Hornick, C. A., & Havel, R. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3623 · Cited by 167
Self-citationSidaway, J. E., Davidson, R. G., McTaggart, F., Orton, T. C., Scott, R. C., Smith, G. J., & Brunskill, N. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000138236.82706.ee · Cited by 154
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Crouse, J. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90692-9 · Cited by 130
Rudling, M. J., Reihnér, E., Einarsson, K., Ewerth, S., & Angelin, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3469 · Cited by 112
Lange, Y., & Steck, T. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13103 · Cited by 105
Metadata
- Authors
- Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Jaramillo, J. J., & Brown, M. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1981-02
- Volume
- 78
- Issue
- 2
- Pages
- 1194-1198
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2077241694
- Cited by
- 421
- References
- 23
- FWCI
- 56.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.